May inflammatory markers be used for monitoring the continuous positive airway pressure effect in patients with obstructive sleep apnea and arrhythmias?

Obstructive sleep apnea syndrome (OSAS) is defined by recurrent episodes of significant reduction or absence of the oro-nasal airflow during sleep, in the presence of thorax and abdominal movements and snoring. The pathophysiological consequences of intermittent hypoxia determined by OSAS are represented by systemic inflammation, the release of free oxygen radicals and activation of the sympathetic nervous system. Cardiac arrhythmias are a frequent comorbidity in patients with OSAS.

Source: Medical Hypotheses - April 10, 2018 Category: Biomedical Science Authors: GN Dediu, CC Diaconu, S. Dumitrache Rujinski, A Iancu, A Balaceanu, I Dina, M Bogdan Source Type: research